AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.
P&G Latin America has a common objective of driving an innovation mindset to solve the most important business challenges related to sustainability. This has been declared a priority for the company and its business units in LATAM which have already defined clear strategies and metrics and are looking for innovative solutions to support their vision and goals.
James Gado - Welcome
Panel moderator: Marcus Dahllof, Program Director, MIT Startup Exchange Panelists: Caleb Harper, Director, OpenAg, MIT Media Lab Dilip Sundaram, President, Corporate, Mahindra Group - Americas Jan Schnorr, CEO, C2Sense Alan Kriz, Strategic Alliance Manager, Crop Science, Bayer Tejal Mody, Managing Director, Rabobank
P&G is looking to partner with companies and emerging disruptors to address key shopper and retailer pain points in urban to deliver a breakthrough experience which disproportionately drives P&G brands.
Please join us at the annual MIT Research and Development Conference: Innovating at the Inflection Point: Creating a Better World on November 15-16, 2022 to hear from MIT researchers, MIT Startup Exchange entrepreneurs, and global business leaders dedicated to innovating to create a better world.
Procter & Gamble is looking for new approaches and technologies that can help them to address their broad range of sustainability challenges/opportunities. The following innovation brief(s) will provide a high-level overview of specific business goals and needs, as well as a high-level overview of what they are looking for in a solution.
This forum will bring together senior executives with thought leaders from MIT to explore the best methods for creating and organizing corporate innovation and venturing groups. We will also discuss how the MIT Industrial Liaison Program (ILP) helps firms engage with the world-leading thinkers at MIT who tackle humanity's most vexing challenges and the entrepreneurs who turn MIT innovations into working solutions.
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.